Abbott India
ABBOTINDIA · Pharma > Pharmaceuticals & Drugs · Chairman: Munir Shaikh Listing date: Jan. 9, 2010 · Employees: 3585 · Mumbai · http://www.abbott.co.in

Stock Price vs Company Growth
1d
0.5%
1w
2.0%
1m
7.1%
3m
2.0%
6m
6.2%
1y
17.3%
5y
11.0%
10y
20.9%
all
24.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 25,951 0.5%
25,164
28,250
Company Overview

Sales
6,929 Cr
Growth: 8.3%
Profit after Tax
1,552 Cr
Growth: 1.8%
Large Cap
55,144 Cr
P/E: 35.5x
Industry P/E: 31.3x
Fundamentals

Sales (Cr) ₹ 6,929
Growth 8.3%
EBITDA 27.3%
P/S 8.0x
Dividend 1.4%
P/E 35.5x
Book Value ₹ 2,247
PEG Ratio 4.3x
ROE 31.4%
P/B 11.6x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
1.64 %
Promoters
Abbott Capital India Limited
50.44 %
Abbott Healthcare Products Limited
17.62 %
British Colloids Limited
6.92 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.
Investors (50)
Followers (16)